Diamond Equity Research Releases Update Note on BioHarvest Sciences Inc. (NASDAQ: BHST)

(NasdaqGM:BHST),(Boerse Frankfurt – Freiverkehr:8MV0.F), New York, May 21, 2025 (GLOBE NEWSWIRE) — Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on BioHarvest Sciences Inc. (NASDAQ: BHST). The update note includes detailed information on the BioHarvest Sciences' financial results, operational updates, business model, […]

Diamond Equity Research Releases Update Note on Almonty Industries, Inc. (TSX: AII) (ASX: AII) (OTCQX: ALMTF)

(OtherOTC:ALMTF),(TSX:AII),(ASX – Trade24:AII.AX), New York, May 21, 2025 (GLOBE NEWSWIRE) — Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note Almonty Industries, Inc. (TSX: AII) (ASX: AII) (FWB: ALI) (OTCPK: ALMT.F). The update note includes detailed information on the Almonty Industries' business model,

Route 92 Medical Announces Results of SUMMIT MAX Clinical Trial Showing Highest First Pass Effect Ever Reported in a Randomized Endovascular Stroke Thrombectomy Study

Data from 250-patient, 31-center, randomized controlled trial presented at European Stroke Organisation Conference Three highest enrolling sites reported 96% delivery of the super-bore HiPoint 88 Reperfusion System to MI occlusions and 84% first pass effect HiPoint 88 Reperfusion System secures 510(k) clearance becoming the first stroke treatment system to achieve super-bore direct aspiration label SAN

Enterprises to Advance Cyber Resilience in Public Cloud with Rubrik and Rackspace Technology

(NASDAQ:RXT),(NYSE:RBRK), SAN ANTONIO, May 21, 2025 (GLOBE NEWSWIRE) — Rubrik (NYSE: RBRK), a leading cyber resilience company, and Rackspace Technology (NASDAQ: RXT), a leading end-to-end hybrid cloud and AI solutions company, have announced Rackspace Cyber Recovery Service – a new managed service for customers operating in public cloud. By combining Rubrik's orchestrated data protection and

LPL Financial Expands Wealth Planning Leadership with New EVP Tara Thompson Popernik

(NASDAQ:LPLA), SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) — LPL Financial LLC, a leading wealth management firm, has appointed Tara Thompson Popernik as Executive Vice President and Head of Wealth Planning. Additionally, Monte Tomasino has joined the company as Executive Vice President of Service Digital Enablement, further solidifying LPL's commitment to delivering top-tier wealth planning

Lelantos Energy Unveils Strategic Initiatives for 2025

(PinkSheets:LNTO),(Pinksheets:LNTO), TUCSON, Ariz., May 21, 2025 (GLOBE NEWSWIRE) — via IBN — Lelantos Energy, a wholly owned subsidiary of Lelantos Holdings, Inc. (OTC PINK: LNTO) (“Lelantos” or the “Company”), is pleased to announce its 2025 strategic initiatives focused on expanding access to renewable energy, working with underserved communities, and driving innovation in tax credit and

GraniteShares launches new YieldBoost ETFs on NVIDIA (NVYY) and Bitcoin (XBTY)

NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) — GraniteShares, an ETF issuer specializing in high conviction ETFs, announced that it is launching two ETFs to add to its existing YieldBOOST lineup – the GraniteShares YieldBOOST NVDA ETF (NVYY) and the GraniteShares YieldBOOST Bitcoin ETF (XBTY). The GraniteShares YieldBOOST NVDA ETF (NVYY) is designed to generate

Transom Capital and SigmaTron International Announce Entry into Merger Agreement

(NASDAQ:SGMA), LOS ANGELES and ELK GROVE VILLAGE, Ill., May 21, 2025 (GLOBE NEWSWIRE) — Transom Capital Group, LLC (“Transom”), an operationally focused middle-market private equity firm, and SigmaTron International, Inc. (NASDAQ: SGMA) (the “Company” or “SigmaTron”), an electronic manufacturing services company, today announced that they have entered into a merger agreement pursuant to which an

Kaida BioPharma Announces New Partnership with Northway Biotech for the Manufacturing of KAD101

Represents significant milestone in the development of KAD101, a novel biologic prolactin receptor antagonist, being initially developed for the treatment of platinum resistant ovarian cancer (PROC) with expansion opportunities into endometrial, uterine and breast cancers Supports advancement of KAD101 towards Phase 1 study targeted to initiate in Q4 2026/Q1 2027 FORT LAUDERDALE, FL, May 21,

Quantum BioPharma Partners with BitGo to Securely Store its Crypto Currency Assets

(NASDAQ:QNTM),(CNSX:QNTM.CN),(Boerse Frankfurt – Freiverkehr:0K91), TORONTO, May 21, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company“), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announced that it has selected BitGo Trust Company (“BitGo”) as one of its partners to

Scroll to Top